Annual Drug Patent Expirations for FASLODEX
Faslodex is a drug marketed by Astrazeneca and is included in one NDA. It is available from one supplier. There are four patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for FASLODEX.
The generic ingredient in FASLODEX is fulvestrant. One supplier is listed for this compound. Additional details are available on the fulvestrant profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com